The 4 analysts offering 12-month price forecasts for BioCardia Inc have a median target of 8.00, with a high estimate of 11.50 and a low estimate of 4.00. The median estimate represents a +492.59% increase from the last price of 1.35.
The current consensus among 4 polled investment analysts is to Buy stock in BioCardia Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.14
Reporting Date Apr 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.